Trazodone Use in Adolescents for Insomnia
Introduction to Trazodone Therapy
- The American Academy of Sleep Medicine explicitly recommends against using trazodone for sleep onset or sleep maintenance insomnia in adults, based on a WEAK recommendation 2, 3
- Trazodone should only be considered after first and second-line treatments have failed, or when comorbid depression or anxiety is present 1
Clinical Efficacy and Safety
- The American Academy of Sleep Medicine recommends cognitive behavioral therapy for insomnia (CBT-I) as the initial treatment for any sleep complaints 1
- Trazodone 50 mg reduced sleep latency by only 10.2 minutes and increased total sleep time by 21.8 minutes—both falling below clinical significance thresholds 2
- No improvement in subjective sleep quality was demonstrated, and the task force judged that harms potentially outweigh benefits 2, 3
Dosing and Monitoring
- Begin with 25 mg at bedtime, not 50 mg, particularly in younger patients to assess tolerability 4
- Titrate gradually by 25 mg increments every 5-7 days as tolerated if higher doses are needed 4
- Assess every 1-2 weeks initially for suicidal ideation, effectiveness, and adverse effects 1
Adverse Effects and Contraindications
- All antidepressants, including trazodone, carry an FDA black box warning for increased suicidal thinking and behavior in children, adolescents, and young adults under age 25 1
- Priapism (prolonged, painful erection)—requires immediate medical attention and may necessitate surgical intervention 2
- Avoid in pregnancy and nursing, and use extreme caution if compromised respiratory function, hepatic impairment, or heart failure is present 1
Special Considerations
- When comorbid depression and insomnia coexist, trazodone can be used in combination with a full-dose SSRI or SNRI antidepressant 1
- When the patient has failed or cannot tolerate FDA-approved hypnotics, trazodone may be considered 1
- When anticholinergic effects of other agents are particularly problematic, trazodone may be an alternative 4